Back
Abits Group, Inc. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
31
ABTS
Abits Group, Inc.
Last Price:
$6.13
Seasonality Move:
-4.69%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$31.53
Seasonality Move:
-6.94%
Sell
31
Abits Group, Inc. (ABTS)
is a Sell
Is Abits Group, Inc. a Buy, Sell or Hold?
-
The current Abits Group, Inc. [ABTS] share price is $6.11. The Score for ABTS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
ABTS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $30.68. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABTS Stock Price Chart
What is Abits Group, Inc.'s stock price today?
-
The Abits Group, Inc. share price today is $6.11The current trend is relatively stagnant and ABTS is experiencing slight buying pressure.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $30.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing slight selling pressure.
ABTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 49.04 | Sell |
| Chaikin Money Flow: | 1029 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.72 - 6.32) | Buy |
| Bollinger Bands (100): | (4.04 - 7.74) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.69 | Buy |
| Relative Strength Index (14 RSI): | 80.55 | Buy |
| Chaikin Money Flow: | 6400058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ABTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.09 | Buy |
| 20-day SMA: | 5.98 | Buy |
| 50-day SMA: | 6.87 | Sell |
| 200-day SMA: | 4.8 | Buy |
| 8-day EMA: | 6.09 | Buy |
| 20-day EMA: | 6.12 | Sell |
| 50-day EMA: | 6.29 | Sell |
| 200-day EMA: | 5.91 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Buy |
| 20-day SMA: | 22.38 | Buy |
| 50-day SMA: | 14.55 | Buy |
| 200-day SMA: | 7.46 | Buy |
| 8-day EMA: | 27.53 | Buy |
| 20-day EMA: | 23.23 | Buy |
| 50-day EMA: | 16.87 | Buy |
| 200-day EMA: | 9.95 | Buy |
Abits Group, Inc. Earnings Growth & ABTS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
Abits Group, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||